11:13 EDT Protagonist Therapeutics (PTGX) trading halted, volatility trading pause
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PTGX:
- Protagonist Therapeutics participates in a conference call with JPMorgan
- Protagonist Therapeutics’ Icotrokinra: A Promising Blockbuster Candidate with Broad Therapeutic Potential
- Protagonist Therapeutics’ Icotrokinra: Promising Phase 2b Results Reinforce Buy Rating
- Protagonist Therapeutics price target raised to $74 from $62 at Clear Street
- Protagonist Therapeutics announces icotrokinra data in UC